Correlation Between BioMark Diagnostics and Star Equity

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioMark Diagnostics and Star Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioMark Diagnostics and Star Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioMark Diagnostics and Star Equity Holdings, you can compare the effects of market volatilities on BioMark Diagnostics and Star Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioMark Diagnostics with a short position of Star Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioMark Diagnostics and Star Equity.

Diversification Opportunities for BioMark Diagnostics and Star Equity

0.87
  Correlation Coefficient

Very poor diversification

The 3 months correlation between BioMark and Star is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding BioMark Diagnostics and Star Equity Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Star Equity Holdings and BioMark Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioMark Diagnostics are associated (or correlated) with Star Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Star Equity Holdings has no effect on the direction of BioMark Diagnostics i.e., BioMark Diagnostics and Star Equity go up and down completely randomly.

Pair Corralation between BioMark Diagnostics and Star Equity

Assuming the 90 days horizon BioMark Diagnostics is expected to generate 1.49 times more return on investment than Star Equity. However, BioMark Diagnostics is 1.49 times more volatile than Star Equity Holdings. It trades about 0.09 of its potential returns per unit of risk. Star Equity Holdings is currently generating about 0.11 per unit of risk. If you would invest  13.00  in BioMark Diagnostics on October 21, 2024 and sell it today you would earn a total of  1.00  from holding BioMark Diagnostics or generate 7.69% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy90.48%
ValuesDaily Returns

BioMark Diagnostics  vs.  Star Equity Holdings

 Performance 
       Timeline  
BioMark Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioMark Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Star Equity Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Star Equity Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

BioMark Diagnostics and Star Equity Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioMark Diagnostics and Star Equity

The main advantage of trading using opposite BioMark Diagnostics and Star Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioMark Diagnostics position performs unexpectedly, Star Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Star Equity will offset losses from the drop in Star Equity's long position.
The idea behind BioMark Diagnostics and Star Equity Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios